ACORN CAPITAL ADVISORS, LLC
20 holdingsFiling period: 2026-06-30Current AUM: $354.8Mestimated from latest prices
| # | Ticker | Company | Shares | Reported Value | Current Value | % Portfolio | Change | Date |
|---|---|---|---|---|---|---|---|---|
| 1 | CGON | CG ONCOLOGY INC | 1.13M | $80.4M | $82.1M | 23.14% | +999 | 2026-06-30 |
| 2 | — | UROGEN PHARMA LTD | 1.67M | $61.6M | $61.6M | 17.36% | -- | 2026-06-30 |
| 3 | TRVI | TREVI THERAPEUTICS INC | 2.14M | $40.0M | $32.3M | 9.09% | -- | 2026-06-30 |
| 4 | CADL | CANDEL THERAPEUTICS INC | 3.50M | $36.0M | $38.9M | 10.96% | -- | 2026-06-30 |
| 5 | PBYI | PUMA BIOTECHNOLOGY INC | 4.13M | $33.5M | $38.2M | 10.77% | -- | 2026-06-30 |
| 6 | JBIO | JADE BIOSCEINCES INC | 986.8K | $21.9M | $17.1M | 4.83% | +200.0K | 2026-06-30 |
| 7 | BCAX | BICARA THERAPEUTICS | 643.4K | $19.1M | $14.6M | 4.11% | -1 | 2026-06-30 |
| 8 | KPTI | KARYOPHARM THERAPEUTICS INC | 1.52M | $14.8M | $2.3M | 0.66% | +1.23M | 2026-06-30 |
| 9 | OKUR | ONKURE THERAPEUTICS INC | 2.84M | $12.9M | $8.3M | 2.35% | -- | 2026-06-30 |
| 10 | HELP | HELUS PHARMA INC. | 1.54M | $10.2M | $20.2M | 5.70% | -- | 2026-06-30 |
| 11 | TARA | PROTARA THERAPEUTICS INC | 1.75M | $6.7M | $6.6M | 1.85% | -- | 2026-06-30 |
| 12 | AURA | AURA BIOSCIENCES INC | 929.1K | $6.6M | $6.4M | 1.81% | +333.3K | 2026-06-30 |
| 13 | LONA | LEONABIO, INC. | 634.5K | $5.8M | $4.6M | 1.29% | -- | 2026-06-30 |
| 14 | VSTM | VERASTEM INC | 1.47M | $5.6M | $10.8M | 3.04% | -- | 2026-06-30 |
| 15 | WHWK | WHITEHAWK THERAPEUTICS INC | 1.14M | $5.2M | $4.7M | 1.31% | -- | 2026-06-30 |
| 16 | QTTB | Q32 BIO INC. | 216.2K | $2.8M | $2.4M | 0.68% | -98,881 | 2026-06-30 |
| 17 | ENGN | EUGENE THERAPEUTICS | 1.27M | $2.2M | $2.4M | 0.68% | -- | 2026-06-30 |
| 18 | JSPR | JASPER THERAPEUTICS | 1.44M | $604K | $818K | 0.23% | +26.7K | 2026-06-30 |
| 19 | BCAB | BIOATLA INC | 108.1K | $447K | $447K | 0.13% | -5,298,219 | 2026-06-30 |
| 20 | VYNE | VYNE THERAPEUTICS INC | 1.4K | -- | -- | -- | -- | 2026-06-30 |
← Scroll →